$LVT.C Establishes Bottom On Increased Volume Shares of Levitee Labs $LVT/$LVT.C have potentially established a bottom on their descent from previous highs of $.49. With relative volume seeing an increase compared to previous weeks, I think prices could be preparing for a trend reversal.
With the 50RSI hitting historic lows, the last time we saw this happen shares went on a ~40% run.
$LVT is a multidisciplinary company operating clinics, pharmacies and naturaceuticals divisions. The company’s goal is to push novel treatment modalities with a key focus on the integration of evidence-based psychedelic medicines and therapies.
With the psychedelics industry set to grow as regulations become lifted, $LVT is definitely high on my list of companies to watch.
Shares of $LVT are currently trading at $.33 and the company is valued at $26.44 million.